Search Results - "Methylphenidate"

Combined chronic oral methylphenidate and fluoxetine treatment increases CB1 receptor density in the somatosensory forelimb region.

Authors: Lantry AM Lu H Marion M et al.

Source: Neuroscience letters [Neurosci Lett] 2025 Dec 10; Vol. 869, pp. 138407. Date of Electronic Publication: 2025 Oct 02.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Scientific Publishers Ireland Country of Publication: Ireland NLM ID: 7600130 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7972 (Electronic) Linking ISSN: 03043940 NLM ISO Abbreviation: Neurosci Lett Subsets: MEDLINE

MeSH Terms: Receptor, Cannabinoid, CB1*/metabolism , Methylphenidate*/pharmacology , Methylphenidate*/administration & dosage , Fluoxetine*/pharmacology , Fluoxetine*/administration & dosage , Selective Serotonin Reuptake Inhibitors*/pharmacology , Selective Serotonin Reuptake Inhibitors*/administration & dosage , Forelimb*/innervation , Somatosensory Cortex*/drug effects , Somatosensory Cortex*/metabolism , Central Nervous System Stimulants*/pharmacology , Central Nervous System Stimulants*/administration & dosage, Animals ; Male ; Rats ; Rimonabant ; Rats, Sprague-Dawley ; Pyrazoles/metabolism ; Piperidines/metabolism ; Autoradiography ; Administration, Oral

Does the Use of Methylphenidate Affect Bone Health? A Systematic Review and Meta-analysis of Preclinical Studies.

Authors: Figueiredo NC Feres MFN Lubker IM et al.

Source: Calcified tissue international [Calcif Tissue Int] 2025 Dec 05; Vol. 116 (1), pp. 146. Date of Electronic Publication: 2025 Dec 05.

Publication Type: Journal Article; Systematic Review; Meta-Analysis; Review

Journal Info: Publisher: Springer Verlag Country of Publication: United States NLM ID: 7905481 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0827 (Electronic) Linking ISSN: 0171967X NLM ISO Abbreviation: Calcif Tissue Int Subsets: MEDLINE

MeSH Terms: Methylphenidate*/adverse effects , Methylphenidate*/pharmacology , Bone Density*/drug effects , Bone and Bones*/drug effects , Central Nervous System Stimulants*/adverse effects , Central Nervous System Stimulants*/pharmacology, Animals ; Humans ; Rats

Headache symptoms in children and adolescents with ADHD: evaluating family history and the role of methylphenidate treatment.

Authors: Nicolardi V Accogli G Macchitella L et al.

Source: Acta neurologica Belgica [Acta Neurol Belg] 2025 Dec; Vol. 125 (6), pp. 1663-1673. Date of Electronic Publication: 2025 Oct 18.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: Italy NLM ID: 0247035 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2240-2993 (Electronic) Linking ISSN: 03009009 NLM ISO Abbreviation: Acta Neurol Belg Subsets: MEDLINE

MeSH Terms: Methylphenidate*/therapeutic use , Methylphenidate*/adverse effects , Attention Deficit Disorder with Hyperactivity*/drug therapy , Attention Deficit Disorder with Hyperactivity*/epidemiology , Central Nervous System Stimulants*/adverse effects , Central Nervous System Stimulants*/therapeutic use , Headache*/epidemiology , Headache*/chemically induced , Headache*/drug therapy, Humans ; Male ; Female ; Child ; Adolescent ; Retrospective Studies ; Cross-Sectional Studies

The synergy of methylphenidate- and reconsolidation-based extinction normalizes ventromedial prefrontal function in drug addiction.

Authors: Ceceli AO King SG Drury KR et al.

Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2025 Nov 11; Vol. 122 (45), pp. e2512310122. Date of Electronic Publication: 2025 Nov 04.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

MeSH Terms: Prefrontal Cortex*/drug effects , Prefrontal Cortex*/physiopathology , Methylphenidate*/pharmacology , Methylphenidate*/administration & dosage , Extinction, Psychological*/drug effects , Cocaine-Related Disorders*/drug therapy , Cocaine-Related Disorders*/physiopathology , Substance-Related Disorders*/drug therapy , Substance-Related Disorders*/physiopathology, Humans ; Male ; Female ; Adult ; Double-Blind Method ; Amygdala/drug effects

Chronic Combined Oral Methylphenidate and Fluoxetine Increases Inflammation in Somatosensory and Mesolimbic Brain Regions.

Authors: Roeser J Lu H Lantry AM et al.

Source: Neurochemical research [Neurochem Res] 2025 Nov 10; Vol. 50 (6), pp. 352. Date of Electronic Publication: 2025 Nov 10.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 7613461 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-6903 (Electronic) Linking ISSN: 03643190 NLM ISO Abbreviation: Neurochem Res Subsets: MEDLINE

MeSH Terms: Fluoxetine*/administration & dosage , Fluoxetine*/toxicity , Fluoxetine*/adverse effects , Methylphenidate*/administration & dosage , Methylphenidate*/toxicity , Methylphenidate*/adverse effects , Selective Serotonin Reuptake Inhibitors*/administration & dosage , Inflammation*/chemically induced , Inflammation*/metabolism , Brain*/drug effects , Brain*/metabolism , Somatosensory Cortex*/drug effects , Somatosensory Cortex*/metabolism, Animals ; Male ; Rats, Sprague-Dawley ; Rats ; Administration, Oral

Pharmacokinetics and Bioequivalence of a Novel Extended-Release Formulation of Methylphenidate Hydrochloride for Attention-Deficit/Hyperactivity Disorder.

Authors: Childress AC Al-Sabbagh A Newcorn JH

Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2025 Nov; Vol. 14 (11), pp. 829-835. Date of Electronic Publication: 2025 Aug 12.

Publication Type: Journal Article; Randomized Controlled Trial; Comparative Study

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

MeSH Terms: Methylphenidate*/pharmacokinetics , Methylphenidate*/administration & dosage , Methylphenidate*/adverse effects , Central Nervous System Stimulants*/pharmacokinetics , Central Nervous System Stimulants*/administration & dosage , Central Nervous System Stimulants*/adverse effects , Attention Deficit Disorder with Hyperactivity*/drug therapy, Humans ; Delayed-Action Preparations/pharmacokinetics ; Therapeutic Equivalency ; Cross-Over Studies ; Male ; Adult ; Female ; Young Adult ; Area Under Curve ; Middle Aged ; Adolescent ; Administration, Oral ; Tablets ; Healthy Volunteers

The Role of Early Exposure Metrics (pAUC 0-3h and C max,0-3h ) in Assessing the Bioequivalence of Methylphenidate Extended-release Products_A Sensitivity Analysis.

Authors: Hsu LF; School of Pharmacy, National Defense Medical Center, Taipei, Taiwan (R.O.C.). Lfhsu@cde.org.tw.; Faculty of Pharmacy, National Yang Ming Chiao Tung University, Taipei, Taiwan (R.O.C.). Lfhsu@cde.org.tw.; School of Pharmacy, Tzu Chi University, Hualien, Taiwan (R.O.C.). Lfhsu@cde.org.tw.; Division of Consultation, Center for Drug Evaluation (CDE), 3F, No.465, Sec.6, Zhongxiao E. Rd, Taipei, 11557, Taiwan (R.O.C.). Lfhsu@cde.org.tw.

Source: The AAPS journal [AAPS J] 2025 Oct 30; Vol. 28 (1), pp. 11. Date of Electronic Publication: 2025 Oct 30.

Publication Type: Journal Article

Journal Info: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

MeSH Terms: Methylphenidate*/pharmacokinetics , Methylphenidate*/administration & dosage , Attention Deficit Disorder with Hyperactivity*/drug therapy , Central Nervous System Stimulants*/pharmacokinetics , Central Nervous System Stimulants*/administration & dosage , Models, Biological*, Therapeutic Equivalency ; Humans ; Delayed-Action Preparations/pharmacokinetics ; Computer Simulation

The disruptive effects of methylphenidate treatment on circadian rhythm in adult female zebrafish and epigenetic transmission of its negative effects to offspring.

Authors: Kutan Başçı AR Arslan-Ergül A

Source: Physiology & behavior [Physiol Behav] 2025 Oct 15; Vol. 300, pp. 115027. Date of Electronic Publication: 2025 Jul 08.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0151504 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-507X (Electronic) Linking ISSN: 00319384 NLM ISO Abbreviation: Physiol Behav Subsets: MEDLINE

MeSH Terms: Methylphenidate*/adverse effects , Methylphenidate*/toxicity , Circadian Rhythm*/drug effects , Epigenesis, Genetic*/drug effects , Central Nervous System Stimulants*/toxicity , Central Nervous System Stimulants*/adverse effects , Prenatal Exposure Delayed Effects*, Animals ; Zebrafish ; Female ; Pregnancy ; DNA Methylation/drug effects

Efficacy and safety of add-on dextromethorphan on irritability in children with ADHD treated with methylphenidate: A randomized double-blind controlled trial.

Authors: Pan PY Yeh CB

Source: Journal of affective disorders [J Affect Disord] 2025 Oct 15; Vol. 387, pp. 119546. Date of Electronic Publication: 2025 May 27.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7906073 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2517 (Electronic) Linking ISSN: 01650327 NLM ISO Abbreviation: J Affect Disord Subsets: MEDLINE

MeSH Terms: Dextromethorphan*/adverse effects , Dextromethorphan*/therapeutic use , Dextromethorphan*/administration & dosage , Methylphenidate*/therapeutic use , Methylphenidate*/adverse effects , Methylphenidate*/administration & dosage , Attention Deficit Disorder with Hyperactivity*/drug therapy , Attention Deficit Disorder with Hyperactivity*/psychology , Attention Deficit Disorder with Hyperactivity*/diagnosis , Irritable Mood*/drug effects , Central Nervous System Stimulants*/therapeutic use , Central Nervous System Stimulants*/adverse effects , Central Nervous System Stimulants*/administration & dosage, Humans ; Child ; Double-Blind Method ; Male ; Female ; Adolescent ; Drug Therapy, Combination ; Treatment Outcome

The effect of methylphenidate and amantadine co-administration on functional outcome of patients with blunt traumatic brain injury: A randomized controlled trial.

Authors: Farrokhi A Mosaed R Khalili H et al.

Source: Acta neurologica Belgica [Acta Neurol Belg] 2025 Oct; Vol. 125 (5), pp. 1277-1285. Date of Electronic Publication: 2025 Jul 07.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Springer Country of Publication: Italy NLM ID: 0247035 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2240-2993 (Electronic) Linking ISSN: 03009009 NLM ISO Abbreviation: Acta Neurol Belg Subsets: MEDLINE

MeSH Terms: Amantadine*/administration & dosage , Amantadine*/therapeutic use , Methylphenidate*/administration & dosage , Methylphenidate*/therapeutic use , Brain Injuries, Traumatic*/drug therapy , Central Nervous System Stimulants*/administration & dosage , Recovery of Function*/drug effects, Humans ; Male ; Female ; Adult ; Double-Blind Method ; Middle Aged ; Treatment Outcome ; Young Adult ; Drug Therapy, Combination

Current insights into the safety and adverse effects of methylphenidate in children, adolescents, and adults - narrative review.

Authors: Silczuk A Lewandowska A Filip M et al.

Source: Pharmacological reports : PR [Pharmacol Rep] 2025 Oct; Vol. 77 (5), pp. 1247-1259. Date of Electronic Publication: 2025 Jul 22.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101234999 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2299-5684 (Electronic) Linking ISSN: 17341140 NLM ISO Abbreviation: Pharmacol Rep Subsets: MEDLINE

MeSH Terms: Methylphenidate*/adverse effects , Methylphenidate*/therapeutic use , Central Nervous System Stimulants*/adverse effects , Central Nervous System Stimulants*/therapeutic use , Central Nervous System Stimulants*/administration & dosage , Attention Deficit Disorder with Hyperactivity*/drug therapy, Humans ; Child ; Adolescent ; Adult

Exploring the sensory profile and pharmacogenetic biomarkers in child and youth ADHD patients undergoing methylphenidate (MPH) treatment: a systematic review conducted in European studies.

Authors: Recarey-Rama S Conde-Pumpido Zubizarreta S Brenlla C et al.

Source: Journal of psychiatric research [J Psychiatr Res] 2025 Oct; Vol. 190, pp. 512-521. Date of Electronic Publication: 2025 Sep 02.

Publication Type: Journal Article; Systematic Review; Review

Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 0376331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1379 (Electronic) Linking ISSN: 00223956 NLM ISO Abbreviation: J Psychiatr Res Subsets: MEDLINE

MeSH Terms: Methylphenidate*/adverse effects , Methylphenidate*/therapeutic use , Methylphenidate*/pharmacology , Attention Deficit Disorder with Hyperactivity*/drug therapy , Attention Deficit Disorder with Hyperactivity*/genetics , Attention Deficit Disorder with Hyperactivity*/complications , Attention Deficit Disorder with Hyperactivity*/physiopathology , Central Nervous System Stimulants*/adverse effects , Central Nervous System Stimulants*/pharmacology , Central Nervous System Stimulants*/therapeutic use, Humans ; Child ; Adolescent ; Europe ; Pharmacogenetics

Consecutive double chiral-switches strategy. ADHD methylphenidate drugs: from two racemates via racemate to enantiomer.

Authors: Agranat I D'Acquarica I

Source: Future medicinal chemistry [Future Med Chem] 2025 Oct; Vol. 17 (20), pp. 2493-2510. Date of Electronic Publication: 2025 Oct 09.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101511162 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1756-8927 (Electronic) Linking ISSN: 17568919 NLM ISO Abbreviation: Future Med Chem Subsets: MEDLINE

MeSH Terms: Methylphenidate*/chemistry , Methylphenidate*/therapeutic use , Attention Deficit Disorder with Hyperactivity*/drug therapy , Central Nervous System Stimulants*/chemistry , Central Nervous System Stimulants*/therapeutic use, Stereoisomerism ; Humans

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors: Storebø OJ Storm MRO Pereira Ribeiro J et al.

Source: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2025 Dec 04; Vol. 12. Cochrane AN: CD009885. Date of Electronic Publication: 2025 Dec 04.

Publication Type: Systematic Review; Journal Article; Meta-Analysis; Review

Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X (Electronic) Linking ISSN: 13616137 NLM ISO Abbreviation: Cochrane Database Syst Rev Subsets: MEDLINE

MeSH Terms: Attention Deficit Disorder with Hyperactivity*/drug therapy , Methylphenidate*/therapeutic use , Methylphenidate*/adverse effects , Central Nervous System Stimulants*/therapeutic use , Central Nervous System Stimulants*/adverse effects, Humans ; Adolescent ; Child ; Randomized Controlled Trials as Topic ; Male ; Female ; Bias ; Quality of Life

Evolution of methylphenidate prescriptions in the region of Occitanie, France, from 2013 to 2021.

Authors: Velay A Alexis J Papinaud L et al.

Source: L'Encephale [Encephale] 2025 Dec; Vol. 51 (6), pp. 651-659. Date of Electronic Publication: 2025 Apr 04.

Publication Type: Journal Article

Journal Info: Publisher: Masson Country of Publication: France NLM ID: 7505643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0013-7006 (Print) Linking ISSN: 00137006 NLM ISO Abbreviation: Encephale Subsets: MEDLINE

MeSH Terms: Methylphenidate*/therapeutic use , Attention Deficit Disorder with Hyperactivity*/drug therapy , Attention Deficit Disorder with Hyperactivity*/epidemiology , Drug Prescriptions*/statistics & numerical data , Central Nervous System Stimulants*/therapeutic use , Practice Patterns, Physicians'*/statistics & numerical data , Practice Patterns, Physicians'*/trends, Humans ; France/epidemiology ; Child ; Adult ; Adolescent ; Female ; Male ; Child, Preschool ; COVID-19/epidemiology ; Young Adult ; Middle Aged ; Infant ; Aged ; Incidence ; SARS-CoV-2 ; Prevalence ; Infant, Newborn

Comparative Bioavailability of Methylphenidate Powder for Prolonged-Release Oral Suspension and Methylphenidate Prolonged-Release Chewable Tablets versus Methylphenidate Immediate-Release Tablets: Phase 1, Single-Dose, Randomised, Crossover Studies in Healthy Adults.

Authors: Ramos-Quiroga JA Forcadell Ferré M Schneider-Pérez A et al.

Source: Clinical drug investigation [Clin Drug Investig] 2025 Dec; Vol. 45 (12), pp. 983-996. Date of Electronic Publication: 2025 Oct 15.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Comparative Study

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE

MeSH Terms: Methylphenidate*/pharmacokinetics , Methylphenidate*/administration & dosage , Methylphenidate*/adverse effects , Methylphenidate*/blood , Central Nervous System Stimulants*/pharmacokinetics , Central Nervous System Stimulants*/administration & dosage , Central Nervous System Stimulants*/adverse effects , Central Nervous System Stimulants*/blood, Humans ; Cross-Over Studies ; Adult ; Male ; Biological Availability ; Tablets ; Delayed-Action Preparations ; Female ; Administration, Oral ; Suspensions ; Young Adult ; Healthy Volunteers ; Powders ; Area Under Curve ; Middle Aged

Methylphenidate stabilizes dynamic brain network organization during tasks probing attention and reward processing in stimulant-naïve children with ADHD.

Authors: Nugiel T Fogleman ND Lyons MG et al.

Source: Translational psychiatry [Transl Psychiatry] 2025 Nov 21; Vol. 15 (1), pp. 488. Date of Electronic Publication: 2025 Nov 21.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101562664 Publication Model: Electronic Cited Medium: Internet ISSN: 2158-3188 (Electronic) Linking ISSN: 21583188 NLM ISO Abbreviation: Transl Psychiatry Subsets: MEDLINE

MeSH Terms: Methylphenidate*/pharmacology , Methylphenidate*/therapeutic use , Attention Deficit Disorder with Hyperactivity*/drug therapy , Attention Deficit Disorder with Hyperactivity*/physiopathology , Attention Deficit Disorder with Hyperactivity*/diagnostic imaging , Reward* , Central Nervous System Stimulants*/pharmacology , Central Nervous System Stimulants*/therapeutic use , Brain*/drug effects , Brain*/physiopathology , Brain*/diagnostic imaging , Attention*/drug effects , Nerve Net*/drug effects , Nerve Net*/physiopathology , Nerve Net*/diagnostic imaging, Humans ; Child ; Male ; Female ; Magnetic Resonance Imaging

Methylphenidate triggers retinal oxidative stress and mitochondrial dysfunction under physiological conditions but has beneficial effects in inflammatory settings.

Authors: Sanches ES Leitão RA Baptista FI et al.

Source: Neuropharmacology [Neuropharmacology] 2025 Nov 15; Vol. 279, pp. 110623. Date of Electronic Publication: 2025 Aug 05.

Publication Type: Journal Article

Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7064 (Electronic) Linking ISSN: 00283908 NLM ISO Abbreviation: Neuropharmacology Subsets: MEDLINE

MeSH Terms: Oxidative Stress*/drug effects , Methylphenidate*/pharmacology , Mitochondria*/drug effects , Mitochondria*/metabolism , Retina*/drug effects , Retina*/metabolism , Central Nervous System Stimulants*/pharmacology, Animals ; Male ; Rats ; Rats, Inbred SHR ; Rats, Inbred WKY ; Inflammation/drug therapy ; Inflammation/metabolism ; Cells, Cultured ; Lipopolysaccharides ; NADPH Oxidase 2/metabolism

Effect of adenosine triphosphate on methylphenidate-induced oxidative and inflammatory kidney damage in rats.

Authors: Yeter B Suleyman Z Bulut S et al.

Source: Drug and chemical toxicology [Drug Chem Toxicol] 2025 Nov; Vol. 48 (6), pp. 1284-1292. Date of Electronic Publication: 2025 Jan 30.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Group Country of Publication: United States NLM ID: 7801723 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-6014 (Electronic) Linking ISSN: 01480545 NLM ISO Abbreviation: Drug Chem Toxicol Subsets: MEDLINE

MeSH Terms: Methylphenidate*/toxicity , Adenosine Triphosphate*/pharmacology , Oxidative Stress*/drug effects , Kidney*/drug effects , Kidney*/pathology , Kidney*/metabolism , Antioxidants*/pharmacology , Antioxidants*/metabolism , Central Nervous System Stimulants*/toxicity , Kidney Diseases*/chemically induced , Kidney Diseases*/prevention & control , Kidney Diseases*/pathology, Animals ; Male ; Rats ; Rats, Wistar ; Blood Urea Nitrogen ; Cytokines/metabolism ; Creatinine/blood ; Inflammation/chemically induced

The utility of long-term methylphenidate in preserving intellectual development in survivors of childhood brain tumour.

Authors: Hagan AJ Hill RM Kingston A et al.

Source: Journal of neuro-oncology [J Neurooncol] 2025 Nov; Vol. 175 (2), pp. 801-812. Date of Electronic Publication: 2025 Jul 31.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE

MeSH Terms: Methylphenidate*/therapeutic use , Brain Neoplasms*/drug therapy , Brain Neoplasms*/psychology , Brain Neoplasms*/complications , Cancer Survivors*/psychology , Central Nervous System Stimulants*/therapeutic use , Intelligence*/drug effects, Humans ; Female ; Male ; Child ; Adolescent ; Bayes Theorem ; Child, Preschool ; Neuropsychological Tests ; Follow-Up Studies